Rolf J Sebaldt Selected Research

Rolf J Sebaldt Research Topics

6	Osteoporosis 01/2006 - 01/2002
4	Metabolic Bone Diseases (Osteopenia) 08/2005 - 01/2003
2	Acne Vulgaris 07/2009 - 11/2007
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2009 - 11/2005
2	Hypertension (High Blood Pressure) 01/2006 - 11/2005
2	Osteoarthritis 02/2005 - 11/2004
1	Dyslipidemias (Dyslipidemia) 01/2009
1	Atrial Fibrillation 05/2007
1	Migraine Disorders (Migraine) 01/2006
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2005
1	Hypercholesterolemia 11/2005
1	Breast Neoplasms (Breast Cancer) 08/2005
1	Rheumatoid Arthritis 02/2005
1	Stroke (Strokes) 02/2005
1	Myocardial Infarction 02/2005
1	Heart Failure 11/2004

3	Alendronate (Alendronate Sodium)FDA LinkGeneric 08/2005 - 01/2003
3	Diphosphonates (Bisphosphonates)IBA 08/2005 - 01/2002
3	Etidronic Acid (HEDP)FDA LinkGeneric 08/2005 - 01/2003
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2009 - 11/2005
2	LipidsIBA 01/2009 - 11/2005
2	Warfarin (Coumadin)FDA LinkGeneric 05/2007 - 11/2004
2	Vitamin D FDA LinkGeneric 08/2005 - 01/2002
2	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 02/2005 - 11/2004
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 02/2005 - 11/2004
1	LDL CholesterolIBA 01/2009
1	oxidized low density lipoproteinIBA 01/2009
1	6-chloropenicillanic acid S-sulfoxideIBA 11/2007
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2006
1	Hypnotics and Sedatives (Sedatives)IBA 01/2006
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2006
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2006
1	ThiazidesIBA 01/2006
1	CalciumIBA 08/2005
1	Tamoxifen FDA LinkGeneric 08/2005
1	Meloxicam (Mobic)FDA LinkGeneric 02/2005

7	Therapeutics 07/2009 - 10/2003
1	Drug Therapy (Chemotherapy) 01/2006